News

Home/News
News 2017-06-21T13:15:59+00:00
November 1, 2017
Rockwell Medical Schedules Third Quarter 2017 Earnings Call
WIXOM, Mich., Nov. 01, 2017 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (RMTI), a fully-integrated biopharmaceutical company targeting end-stage renal disease (ESRD) and chronic kidney disease ...
November 1, 2017
ASPiRA Labs Announces a Major Coverage Milestone - A 27% Increase in Covered Lives for OVA1
AUSTIN, Texas, Nov. 1, 2017 /PRNewswire/ -- ASPiRA Labs, a Vermillion company (VRML) and the exclusive distributor of OVA1 (Multivariate Index Assay) (MIA), today announced ...
November 1, 2017
Catalyst Biosciences Announces Oral Presentation on Interim Phase 1/2 Data of Subcutaneous CB 2679d/ISU304 in Hemophilia B Patients at American Society for Hematology
SOUTH SAN FRANCISCO, Calif., Nov. 01, 2017 (GLOBE NEWSWIRE) -- Catalyst Biosciences, Inc. (CBIO), a clinical-stage biopharmaceutical company focused on developing novel medicines to address ...
November 1, 2017
Kitov Pharmaceuticals Announces Receipt of FDA's Favorable Response to NT219's pre-IND Meeting Package
TEL AVIV, Israel, Nov. 1, 2017 /PRNewswire/ -- Kitov Pharmaceuticals (NASDAQ: KTOV; TASE: KTOV), an innovative biopharmaceutical company, announced today that it has received the ...
November 1, 2017
Aptose to Present New CG’806 Data at the 2017 ASH Annual Meeting
SAN DIEGO and TORONTO, Nov. 01, 2017 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“Aptose” or the “Company”) (APTO), (APS.TO), a clinical-stage company developing highly differentiated ...
November 1, 2017
Ignyta to Present at Credit Suisse 26th Annual Healthcare Conference
SAN DIEGO--(BUSINESS WIRE)--Ignyta, Inc. (RXDX), a biotechnology company focused on precision medicine in oncology, announced today that Jacob Chacko, M.D., its Chief Financial Officer, will make ...
November 1, 2017
DURECT Corporation Announces Third Quarter 2017 Financial Results and Provides Corporate Update
CUPERTINO, Calif., Nov. 1, 2017 /PRNewswire/ -- DURECT Corporation (DRRX) today announced financial results for the three months ended September 30, 2017 and provided a corporate ...
November 1, 2017
Windtree Successfully Completes Financial Restructuring Program
WARRINGTON, Pa. and SHATIN, HONG KONG, Nov. 1, 2017 /PRNewswire/ -- Windtree Therapeutics, Inc. (WINT), a biotechnology company focused on developing aerosolized KL4 surfactant therapies ...
November 1, 2017
Prothena to Participate in the Credit Suisse 26th Annual Healthcare Conference
DUBLIN, Ireland, Nov. 01, 2017 (GLOBE NEWSWIRE) -- Prothena Corporation plc (PRTA), a late-stage clinical biotechnology company focused on the discovery, development and commercialization of ...
November 1, 2017
Mirati Therapeutics Reports Third Quarter 2017 Financial Results
SAN DIEGO, Nov. 1, 2017 /PRNewswire/ -- Mirati Therapeutics, Inc. (MRTX), a clinical stage oncology biotechnology company, reported financial results for the third quarter 2017. ...
October 31, 2017
Basilea's Chief Medical Officer Prof. Achim Kaufhold to retire and Dr. Marc Engelhardt named as successor
Basel, Switzerland, October 31, 2017 - Basilea Pharmaceutica Ltd. (SIX:BSLN) reported today that Prof. Achim Kaufhold will retire after seven years with the company. Basilea ...
October 31, 2017
DelMar Pharmaceuticals Presents Data Supporting VAL-083 as a Component of Combination Chemotherapy Regimens for the Treatment of Solid Tumors including Brain and Ovarian Cancer
VANCOUVER, British Columbia and MENLO PARK, Calif., Oct. 31, 2017 /PRNewswire/ -- DelMar Pharmaceuticals, Inc. (DMPI) ("DelMar" and "the Company"), a biopharmaceutical company focused on ...
October 31, 2017
Spring Bank Pharmaceuticals Provides Corporate Update and Reports Third Quarter 2017 Financial and Operational Results
HOPKINTON, Mass., Oct. 31, 2017 (GLOBE NEWSWIRE) -- Spring Bank Pharmaceuticals, Inc. (SBPH), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of viral ...
October 31, 2017
Zogenix to Release Third Quarter 2017 Financial Results and Host Conference Call and Webcast on November 7
EMERYVILLE, Calif., Oct. 31, 2017 (GLOBE NEWSWIRE) -- Zogenix, Inc. (ZGNX), a pharmaceutical company developing therapies for the treatment of rare central nervous system (CNS) ...
October 31, 2017
CymaBay Announces the Appointment of Sujal Shah as President and Chief Executive Officer
NEWARK, Calif., Oct. 31, 2017 (GLOBE NEWSWIRE) -- CymaBay Therapeutics, Inc. (CBAY), a clinical-stage biopharmaceutical company focused on developing therapies for liver and other chronic ...
October 31, 2017
Arcturus Therapeutics and Synthetic Genomics Announce Strategic Alliance to Develop Next-Generation Vaccines and Therapeutics
SAN DIEGO, Oct. 31, 2017 /PRNewswire/ -- Arcturus Therapeutics, Inc., a leading RNA medicines company, and Synthetic Genomics, Inc. announced today that they have entered into ...
October 31, 2017
Minerva Neurosciences Names Dr. Justine Lalonde as Senior Vice President, Product Strategy
WALTHAM, Mass., Oct. 31, 2017 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central ...
October 31, 2017
Arena Pharmaceuticals to Present at the Credit Suisse Healthcare Conference on November 8
SAN DIEGO, Oct. 31, 2017 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (ARNA) today announced that Kevin R. Lind, the Company's Executive Vice President and Chief Financial Officer, ...
October 31, 2017
VBI Vaccines Announces Closing of Public Offering and Concurrent Registered Direct Offering of Common Shares
CAMBRIDGE, Mass., Oct. 31, 2017 (GLOBE NEWSWIRE) -- VBI Vaccines Inc. (VBIV) (VBV.TO) (VBI), a commercial-stage biopharmaceutical company developing next-generation infectious disease and immuno-oncology vaccines, ...
October 31, 2017
Aimmune Therapeutics Announces Publication in The Journal of Allergy and Clinical Immunology: In Practice of Positive AR101 Data from ARC001 Phase 2 Clinical Trial
BRISBANE, Calif.--(BUSINESS WIRE)-- Aimmune Therapeutics, Inc. (AIMT), a biopharmaceutical company developing treatments for potentially life-threatening food allergies, today announced the online publication of positive data from ...
Page 13 of 48